Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Vaccines is a Canadian biotechnology company specializing in the development of novel vaccines for infectious diseases, with a primary focus on animal health. Spun out from the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan, the company leverages advanced recombinant protein platforms to address significant unmet needs in the swine industry. Their lead programs target Streptococcus suis and Actinobacillus pleuropneumoniae, pathogens that cause severe respiratory and systemic infections in pigs. By providing effective vaccine solutions, Aurora Vaccines aims to reduce the reliance on antibiotics in livestock production and improve overall animal welfare and food safety.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora Vaccines.